Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped GPDC decided to terminate the study

Conditions

DRUG: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
DRUG: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
DRUG: Candesartan Cilexetil
DRUG: Candesartan matching placebo
DRUG: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106) 30/16mg matching placebo
DRUG: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)

Bayer